Russian Hackers Targeting COVID-19 Vaccine Developers, According to UK, US & Canada 16/07/2020 Grace Ren A notorious hacking group with ties to Russia’s intelligence network has been targeting COVID-19 vaccine developers, according to the United States, United Kingdom, and Canadian government. APT29, also known as ‘The Dukes’ or ‘Cozy Bear,’ has been organizing cyber attacks in an effort to steal confidential information regarding COVID-19 vaccine development and research, according to […] Continue reading -> 150 Countries Sign Up For COVID-19 Vaccine Global Access Facility; Moderna Releases Promising Peer-Reviewed Phase I Vaccine Trial Results 15/07/2020 Grace Ren Some 75 new countries have submitted expressions of interest to join the COVAX Facility, potentially supporting 90 other countries who have already joined the COVAX Advanced Market Commitment initiative created to pool demand and secure lower prices for bulk purchases of a COVID-19 vaccine. Meanwhile, Moderna is pulling ahead in the COVID-19 vaccine rat race […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> US Secures Most Of World’s Remdesivir For Next 3 Months; Swine Flu Variant Circulating In China Not A New Virus, Says WHO Experts 02/07/2020 Grace Ren The United States has secured almost all of Gilead Sciences’ projected production of remdesivir – an antiviral that was shown to reduce hospitalization times for COVID-19 patients- for the next three months. US Health and Human Services (HHS) has secured 100 percent of Gilead’s projected production for July (94,200 treatment courses), 90 percent of production […] Continue reading -> Pfizer COVID-19 Vaccine Shows Promising Early Results; Induces Immune Response In Healthy Volunteers 01/07/2020 Grace Ren A COVID-19 vaccine candidate under development by pharma giant Pfizer and biotech firm BioNTech showed promise in interim results released Wednesday. The vaccine candidate, BNT162b1, was able to induce the formation of antibodies that neutralized SARS-CoV-2, the virus that causes COVID-19, in all participants who received doses between 10ug to 30ug, according to a report […] Continue reading -> World Surpasses 500,000 COVID-19 Deaths; Medicines Access Experts Challenge US $2340 Per Remdesivir Treatment Course Price Set By Gilead For Developed Countries 29/06/2020 Grace Ren A six-vial five-day course of remdesivir – a promising COVID-19 treatment – will be priced at US $2340, or $390 per vial for developed countries, Gilead Sciences Chief Executive Officer Daniel O’Day wrote in an open letter on Monday. “Earlier hospital discharge [thanks to treatment by remdesivir] would result in hospital savings of approximately $12,000 […] Continue reading -> Massive Mobilization Of US $31.3 Billion Required For COVID-19 Diagnostics, Drugs & Vaccines Accelerator 26/06/2020 Grace Ren The World Health Organization aims to raise a whopping US $31.3 billion to fund the ambitious goals of the Access to COVID-19 Tools (ACT) Accelerator; a multi-stakeholder initiative that aims to develop and deploy diagnostics, drugs, and vaccines to control the virus. But so far, only $US 3.4 billion has been pledged towards the initial […] Continue reading -> South African Volunteers Join Oxford COVID-19 Vaccine Trial 23/06/2020 Kerry Cullinan 24 June 2020 (Cape Town, South Africa) – From today, South Africans volunteers will join thousands of people in the UK, US and Brazil in testing a COVID-19 candidate vaccine developed by the Oxford Jenner Institute. The South African Ox1Cov-19 Vaccine VIDA-Trial will involve 2,000 people, including 50 people living with HIV, in a collaboration […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
150 Countries Sign Up For COVID-19 Vaccine Global Access Facility; Moderna Releases Promising Peer-Reviewed Phase I Vaccine Trial Results 15/07/2020 Grace Ren Some 75 new countries have submitted expressions of interest to join the COVAX Facility, potentially supporting 90 other countries who have already joined the COVAX Advanced Market Commitment initiative created to pool demand and secure lower prices for bulk purchases of a COVID-19 vaccine. Meanwhile, Moderna is pulling ahead in the COVID-19 vaccine rat race […] Continue reading -> COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> US Secures Most Of World’s Remdesivir For Next 3 Months; Swine Flu Variant Circulating In China Not A New Virus, Says WHO Experts 02/07/2020 Grace Ren The United States has secured almost all of Gilead Sciences’ projected production of remdesivir – an antiviral that was shown to reduce hospitalization times for COVID-19 patients- for the next three months. US Health and Human Services (HHS) has secured 100 percent of Gilead’s projected production for July (94,200 treatment courses), 90 percent of production […] Continue reading -> Pfizer COVID-19 Vaccine Shows Promising Early Results; Induces Immune Response In Healthy Volunteers 01/07/2020 Grace Ren A COVID-19 vaccine candidate under development by pharma giant Pfizer and biotech firm BioNTech showed promise in interim results released Wednesday. The vaccine candidate, BNT162b1, was able to induce the formation of antibodies that neutralized SARS-CoV-2, the virus that causes COVID-19, in all participants who received doses between 10ug to 30ug, according to a report […] Continue reading -> World Surpasses 500,000 COVID-19 Deaths; Medicines Access Experts Challenge US $2340 Per Remdesivir Treatment Course Price Set By Gilead For Developed Countries 29/06/2020 Grace Ren A six-vial five-day course of remdesivir – a promising COVID-19 treatment – will be priced at US $2340, or $390 per vial for developed countries, Gilead Sciences Chief Executive Officer Daniel O’Day wrote in an open letter on Monday. “Earlier hospital discharge [thanks to treatment by remdesivir] would result in hospital savings of approximately $12,000 […] Continue reading -> Massive Mobilization Of US $31.3 Billion Required For COVID-19 Diagnostics, Drugs & Vaccines Accelerator 26/06/2020 Grace Ren The World Health Organization aims to raise a whopping US $31.3 billion to fund the ambitious goals of the Access to COVID-19 Tools (ACT) Accelerator; a multi-stakeholder initiative that aims to develop and deploy diagnostics, drugs, and vaccines to control the virus. But so far, only $US 3.4 billion has been pledged towards the initial […] Continue reading -> South African Volunteers Join Oxford COVID-19 Vaccine Trial 23/06/2020 Kerry Cullinan 24 June 2020 (Cape Town, South Africa) – From today, South Africans volunteers will join thousands of people in the UK, US and Brazil in testing a COVID-19 candidate vaccine developed by the Oxford Jenner Institute. The South African Ox1Cov-19 Vaccine VIDA-Trial will involve 2,000 people, including 50 people living with HIV, in a collaboration […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID-19 Vaccine Nationalism Limits Africa’s Options 11/07/2020 Paul Adepoju Ibadan, Nigeria – The World Health Organisation (WHO) is advocating for equitable access to effective COVID-19 vaccines but developments surrounding the race to a vaccine suggest this may be extremely difficult. And health policy leaders in Africa and other low and middle-income countries are increasingly worried about their prospects for being pushed to the back […] Continue reading -> Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> US Secures Most Of World’s Remdesivir For Next 3 Months; Swine Flu Variant Circulating In China Not A New Virus, Says WHO Experts 02/07/2020 Grace Ren The United States has secured almost all of Gilead Sciences’ projected production of remdesivir – an antiviral that was shown to reduce hospitalization times for COVID-19 patients- for the next three months. US Health and Human Services (HHS) has secured 100 percent of Gilead’s projected production for July (94,200 treatment courses), 90 percent of production […] Continue reading -> Pfizer COVID-19 Vaccine Shows Promising Early Results; Induces Immune Response In Healthy Volunteers 01/07/2020 Grace Ren A COVID-19 vaccine candidate under development by pharma giant Pfizer and biotech firm BioNTech showed promise in interim results released Wednesday. The vaccine candidate, BNT162b1, was able to induce the formation of antibodies that neutralized SARS-CoV-2, the virus that causes COVID-19, in all participants who received doses between 10ug to 30ug, according to a report […] Continue reading -> World Surpasses 500,000 COVID-19 Deaths; Medicines Access Experts Challenge US $2340 Per Remdesivir Treatment Course Price Set By Gilead For Developed Countries 29/06/2020 Grace Ren A six-vial five-day course of remdesivir – a promising COVID-19 treatment – will be priced at US $2340, or $390 per vial for developed countries, Gilead Sciences Chief Executive Officer Daniel O’Day wrote in an open letter on Monday. “Earlier hospital discharge [thanks to treatment by remdesivir] would result in hospital savings of approximately $12,000 […] Continue reading -> Massive Mobilization Of US $31.3 Billion Required For COVID-19 Diagnostics, Drugs & Vaccines Accelerator 26/06/2020 Grace Ren The World Health Organization aims to raise a whopping US $31.3 billion to fund the ambitious goals of the Access to COVID-19 Tools (ACT) Accelerator; a multi-stakeholder initiative that aims to develop and deploy diagnostics, drugs, and vaccines to control the virus. But so far, only $US 3.4 billion has been pledged towards the initial […] Continue reading -> South African Volunteers Join Oxford COVID-19 Vaccine Trial 23/06/2020 Kerry Cullinan 24 June 2020 (Cape Town, South Africa) – From today, South Africans volunteers will join thousands of people in the UK, US and Brazil in testing a COVID-19 candidate vaccine developed by the Oxford Jenner Institute. The South African Ox1Cov-19 Vaccine VIDA-Trial will involve 2,000 people, including 50 people living with HIV, in a collaboration […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Antimicrobial Resistance (AMR) Action Fund Will Infuse US$1 Billion Into Search For New Antibiotics 09/07/2020 Svĕt Lustig Vijay & Grace Ren A new Antimicrobial Resistance (AMR) Action Fund will inject nearly US $1 billion into the collapsing antibiotic development pipeline, aiming to bring two to four new antibiotics to patients by 2030. The investment, organized by the International Federation of Pharmaceutical Manufacturers & Associations and 23 different pharma companies, is the biggest single investment in antibiotic […] Continue reading -> World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> US Secures Most Of World’s Remdesivir For Next 3 Months; Swine Flu Variant Circulating In China Not A New Virus, Says WHO Experts 02/07/2020 Grace Ren The United States has secured almost all of Gilead Sciences’ projected production of remdesivir – an antiviral that was shown to reduce hospitalization times for COVID-19 patients- for the next three months. US Health and Human Services (HHS) has secured 100 percent of Gilead’s projected production for July (94,200 treatment courses), 90 percent of production […] Continue reading -> Pfizer COVID-19 Vaccine Shows Promising Early Results; Induces Immune Response In Healthy Volunteers 01/07/2020 Grace Ren A COVID-19 vaccine candidate under development by pharma giant Pfizer and biotech firm BioNTech showed promise in interim results released Wednesday. The vaccine candidate, BNT162b1, was able to induce the formation of antibodies that neutralized SARS-CoV-2, the virus that causes COVID-19, in all participants who received doses between 10ug to 30ug, according to a report […] Continue reading -> World Surpasses 500,000 COVID-19 Deaths; Medicines Access Experts Challenge US $2340 Per Remdesivir Treatment Course Price Set By Gilead For Developed Countries 29/06/2020 Grace Ren A six-vial five-day course of remdesivir – a promising COVID-19 treatment – will be priced at US $2340, or $390 per vial for developed countries, Gilead Sciences Chief Executive Officer Daniel O’Day wrote in an open letter on Monday. “Earlier hospital discharge [thanks to treatment by remdesivir] would result in hospital savings of approximately $12,000 […] Continue reading -> Massive Mobilization Of US $31.3 Billion Required For COVID-19 Diagnostics, Drugs & Vaccines Accelerator 26/06/2020 Grace Ren The World Health Organization aims to raise a whopping US $31.3 billion to fund the ambitious goals of the Access to COVID-19 Tools (ACT) Accelerator; a multi-stakeholder initiative that aims to develop and deploy diagnostics, drugs, and vaccines to control the virus. But so far, only $US 3.4 billion has been pledged towards the initial […] Continue reading -> South African Volunteers Join Oxford COVID-19 Vaccine Trial 23/06/2020 Kerry Cullinan 24 June 2020 (Cape Town, South Africa) – From today, South Africans volunteers will join thousands of people in the UK, US and Brazil in testing a COVID-19 candidate vaccine developed by the Oxford Jenner Institute. The South African Ox1Cov-19 Vaccine VIDA-Trial will involve 2,000 people, including 50 people living with HIV, in a collaboration […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Trade Organization TRIPS Council Needs To Reassess Mechanisms For Access To Drugs In COVID-19 Era 06/07/2020 Kerry Cullinan Cape Town, South Africa – The US government’s recent purchase of almost the entire available stock of Gilead’s remdesivir – a medicine shown to help speed up the recovery of people who are moderately sick with COVID-19 – has raised fears about whether poorer countries will also be left in the dust if a vaccine […] Continue reading -> US Secures Most Of World’s Remdesivir For Next 3 Months; Swine Flu Variant Circulating In China Not A New Virus, Says WHO Experts 02/07/2020 Grace Ren The United States has secured almost all of Gilead Sciences’ projected production of remdesivir – an antiviral that was shown to reduce hospitalization times for COVID-19 patients- for the next three months. US Health and Human Services (HHS) has secured 100 percent of Gilead’s projected production for July (94,200 treatment courses), 90 percent of production […] Continue reading -> Pfizer COVID-19 Vaccine Shows Promising Early Results; Induces Immune Response In Healthy Volunteers 01/07/2020 Grace Ren A COVID-19 vaccine candidate under development by pharma giant Pfizer and biotech firm BioNTech showed promise in interim results released Wednesday. The vaccine candidate, BNT162b1, was able to induce the formation of antibodies that neutralized SARS-CoV-2, the virus that causes COVID-19, in all participants who received doses between 10ug to 30ug, according to a report […] Continue reading -> World Surpasses 500,000 COVID-19 Deaths; Medicines Access Experts Challenge US $2340 Per Remdesivir Treatment Course Price Set By Gilead For Developed Countries 29/06/2020 Grace Ren A six-vial five-day course of remdesivir – a promising COVID-19 treatment – will be priced at US $2340, or $390 per vial for developed countries, Gilead Sciences Chief Executive Officer Daniel O’Day wrote in an open letter on Monday. “Earlier hospital discharge [thanks to treatment by remdesivir] would result in hospital savings of approximately $12,000 […] Continue reading -> Massive Mobilization Of US $31.3 Billion Required For COVID-19 Diagnostics, Drugs & Vaccines Accelerator 26/06/2020 Grace Ren The World Health Organization aims to raise a whopping US $31.3 billion to fund the ambitious goals of the Access to COVID-19 Tools (ACT) Accelerator; a multi-stakeholder initiative that aims to develop and deploy diagnostics, drugs, and vaccines to control the virus. But so far, only $US 3.4 billion has been pledged towards the initial […] Continue reading -> South African Volunteers Join Oxford COVID-19 Vaccine Trial 23/06/2020 Kerry Cullinan 24 June 2020 (Cape Town, South Africa) – From today, South Africans volunteers will join thousands of people in the UK, US and Brazil in testing a COVID-19 candidate vaccine developed by the Oxford Jenner Institute. The South African Ox1Cov-19 Vaccine VIDA-Trial will involve 2,000 people, including 50 people living with HIV, in a collaboration […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US Secures Most Of World’s Remdesivir For Next 3 Months; Swine Flu Variant Circulating In China Not A New Virus, Says WHO Experts 02/07/2020 Grace Ren The United States has secured almost all of Gilead Sciences’ projected production of remdesivir – an antiviral that was shown to reduce hospitalization times for COVID-19 patients- for the next three months. US Health and Human Services (HHS) has secured 100 percent of Gilead’s projected production for July (94,200 treatment courses), 90 percent of production […] Continue reading -> Pfizer COVID-19 Vaccine Shows Promising Early Results; Induces Immune Response In Healthy Volunteers 01/07/2020 Grace Ren A COVID-19 vaccine candidate under development by pharma giant Pfizer and biotech firm BioNTech showed promise in interim results released Wednesday. The vaccine candidate, BNT162b1, was able to induce the formation of antibodies that neutralized SARS-CoV-2, the virus that causes COVID-19, in all participants who received doses between 10ug to 30ug, according to a report […] Continue reading -> World Surpasses 500,000 COVID-19 Deaths; Medicines Access Experts Challenge US $2340 Per Remdesivir Treatment Course Price Set By Gilead For Developed Countries 29/06/2020 Grace Ren A six-vial five-day course of remdesivir – a promising COVID-19 treatment – will be priced at US $2340, or $390 per vial for developed countries, Gilead Sciences Chief Executive Officer Daniel O’Day wrote in an open letter on Monday. “Earlier hospital discharge [thanks to treatment by remdesivir] would result in hospital savings of approximately $12,000 […] Continue reading -> Massive Mobilization Of US $31.3 Billion Required For COVID-19 Diagnostics, Drugs & Vaccines Accelerator 26/06/2020 Grace Ren The World Health Organization aims to raise a whopping US $31.3 billion to fund the ambitious goals of the Access to COVID-19 Tools (ACT) Accelerator; a multi-stakeholder initiative that aims to develop and deploy diagnostics, drugs, and vaccines to control the virus. But so far, only $US 3.4 billion has been pledged towards the initial […] Continue reading -> South African Volunteers Join Oxford COVID-19 Vaccine Trial 23/06/2020 Kerry Cullinan 24 June 2020 (Cape Town, South Africa) – From today, South Africans volunteers will join thousands of people in the UK, US and Brazil in testing a COVID-19 candidate vaccine developed by the Oxford Jenner Institute. The South African Ox1Cov-19 Vaccine VIDA-Trial will involve 2,000 people, including 50 people living with HIV, in a collaboration […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pfizer COVID-19 Vaccine Shows Promising Early Results; Induces Immune Response In Healthy Volunteers 01/07/2020 Grace Ren A COVID-19 vaccine candidate under development by pharma giant Pfizer and biotech firm BioNTech showed promise in interim results released Wednesday. The vaccine candidate, BNT162b1, was able to induce the formation of antibodies that neutralized SARS-CoV-2, the virus that causes COVID-19, in all participants who received doses between 10ug to 30ug, according to a report […] Continue reading -> World Surpasses 500,000 COVID-19 Deaths; Medicines Access Experts Challenge US $2340 Per Remdesivir Treatment Course Price Set By Gilead For Developed Countries 29/06/2020 Grace Ren A six-vial five-day course of remdesivir – a promising COVID-19 treatment – will be priced at US $2340, or $390 per vial for developed countries, Gilead Sciences Chief Executive Officer Daniel O’Day wrote in an open letter on Monday. “Earlier hospital discharge [thanks to treatment by remdesivir] would result in hospital savings of approximately $12,000 […] Continue reading -> Massive Mobilization Of US $31.3 Billion Required For COVID-19 Diagnostics, Drugs & Vaccines Accelerator 26/06/2020 Grace Ren The World Health Organization aims to raise a whopping US $31.3 billion to fund the ambitious goals of the Access to COVID-19 Tools (ACT) Accelerator; a multi-stakeholder initiative that aims to develop and deploy diagnostics, drugs, and vaccines to control the virus. But so far, only $US 3.4 billion has been pledged towards the initial […] Continue reading -> South African Volunteers Join Oxford COVID-19 Vaccine Trial 23/06/2020 Kerry Cullinan 24 June 2020 (Cape Town, South Africa) – From today, South Africans volunteers will join thousands of people in the UK, US and Brazil in testing a COVID-19 candidate vaccine developed by the Oxford Jenner Institute. The South African Ox1Cov-19 Vaccine VIDA-Trial will involve 2,000 people, including 50 people living with HIV, in a collaboration […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
World Surpasses 500,000 COVID-19 Deaths; Medicines Access Experts Challenge US $2340 Per Remdesivir Treatment Course Price Set By Gilead For Developed Countries 29/06/2020 Grace Ren A six-vial five-day course of remdesivir – a promising COVID-19 treatment – will be priced at US $2340, or $390 per vial for developed countries, Gilead Sciences Chief Executive Officer Daniel O’Day wrote in an open letter on Monday. “Earlier hospital discharge [thanks to treatment by remdesivir] would result in hospital savings of approximately $12,000 […] Continue reading -> Massive Mobilization Of US $31.3 Billion Required For COVID-19 Diagnostics, Drugs & Vaccines Accelerator 26/06/2020 Grace Ren The World Health Organization aims to raise a whopping US $31.3 billion to fund the ambitious goals of the Access to COVID-19 Tools (ACT) Accelerator; a multi-stakeholder initiative that aims to develop and deploy diagnostics, drugs, and vaccines to control the virus. But so far, only $US 3.4 billion has been pledged towards the initial […] Continue reading -> South African Volunteers Join Oxford COVID-19 Vaccine Trial 23/06/2020 Kerry Cullinan 24 June 2020 (Cape Town, South Africa) – From today, South Africans volunteers will join thousands of people in the UK, US and Brazil in testing a COVID-19 candidate vaccine developed by the Oxford Jenner Institute. The South African Ox1Cov-19 Vaccine VIDA-Trial will involve 2,000 people, including 50 people living with HIV, in a collaboration […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Massive Mobilization Of US $31.3 Billion Required For COVID-19 Diagnostics, Drugs & Vaccines Accelerator 26/06/2020 Grace Ren The World Health Organization aims to raise a whopping US $31.3 billion to fund the ambitious goals of the Access to COVID-19 Tools (ACT) Accelerator; a multi-stakeholder initiative that aims to develop and deploy diagnostics, drugs, and vaccines to control the virus. But so far, only $US 3.4 billion has been pledged towards the initial […] Continue reading -> South African Volunteers Join Oxford COVID-19 Vaccine Trial 23/06/2020 Kerry Cullinan 24 June 2020 (Cape Town, South Africa) – From today, South Africans volunteers will join thousands of people in the UK, US and Brazil in testing a COVID-19 candidate vaccine developed by the Oxford Jenner Institute. The South African Ox1Cov-19 Vaccine VIDA-Trial will involve 2,000 people, including 50 people living with HIV, in a collaboration […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
South African Volunteers Join Oxford COVID-19 Vaccine Trial 23/06/2020 Kerry Cullinan 24 June 2020 (Cape Town, South Africa) – From today, South Africans volunteers will join thousands of people in the UK, US and Brazil in testing a COVID-19 candidate vaccine developed by the Oxford Jenner Institute. The South African Ox1Cov-19 Vaccine VIDA-Trial will involve 2,000 people, including 50 people living with HIV, in a collaboration […] Continue reading -> Posts navigation Older postsNewer posts